New Elsevier journal highlights osteoporosis in men

Topic the theme for World Osteoporosis Day 2004

Topic the theme for World Osteoporosis Day 2004.

Amsterdam, 20 October 2004 – Osteoporosis is a widespread health problem in men, although most individuals diagnosed with osteoporosis are post-menopausal women. Many healthcare providers mistakenly still regard the bone disease a health concern for women only. Elsevier’s new Journal of Men’s Health and Gender is helping to raise overall awareness about the disease’s prevalence in men, the 2004 theme of the International Osteoporosis Foundation’s World Osteoporosis Day, by publishing a series of articles on osteoporosis in men.

Doctors often fail to diagnose the disease, although male patients over 50 may have a family history of the osteoporosis, and may indeed exhibit and experience clear signs of the ailment, such as loss of height or bone fracture. It is estimated that one in five men over the age of 50 will experience at least one osteoporosis-related bone fracture in their lifetime.

The JMHG series covers epidemiology, risk factors, diagnosis and prevention, including a comprehensive discussion on therapies and therapeutic agents for treating the disease. Professor Edith M. C. Lau’s article, “Osteoporosis in men,” which introduces the series, provides an overview of osteoporosis in men. Warns Professor Lau, “Further research into the validity of diagnostic criteria, risk factors and emerging therapeutic agents for osteoporosis in men is…urgently required.”

In the second article entitled, “Osteoporosis: Assessment for diagnosis, evaluation and treatment,” Dr. Leonard K. H. Koh observes that “translating the knowledge gained from research on osteoporosis into a rational approach…[for]…clinical practice is challenging.” As many as 22% of men over the age of 50 are affected, and the prevalence rate increases with increasing age. He points out that bone fractures, a frequent consequence, are linked to a higher incidence of disability, mortality, morbidity, and health care costs, yet…” For the majority of patients without a prior fracture, osteoporosis is silent and has to be looked for….” Concludes Koh, “Although the challenge is to improve on the effectiveness of diagnostics and therapeutics, probably the greater challenge is to develop cost-efficient strategies to detect and manage the majority of people at risk or suffering from this worldwide epidemic.“

# # #

About World Osteoporosis Day

World Osteoporosis Day is sponsored by The International Osteoporosis Foundation (IOF) (, an international non-governmental organization based in Berne, Switzerland whose mission is to advance the understanding of osteoporosis and to promote prevention, diagnosis and treatment of the disease worldwide. World Osteoporosis Day 2004 will focus on raising awareness about osteoporosis in men through activities such as special public and media events and lectures to health professionals.

About Elsevier
Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we’re committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers.

Marike Westra
Tel: +31-20-485-2736